Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sulfonamide derivative as well as preparation method and application thereof

A technology of derivatives and sulfonamides, applied in the field of sulfonamide derivatives and their preparation

Inactive Publication Date: 2019-04-26
ZUNYI MEDICAL UNIVERSITY
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] In recent years, with the widespread use and abuse of antibacterial drugs in clinical practice, drug resistance has become a difficult global problem. Many patients with bacterial infections are facing a situation where there is no cure. bring unprecedented challenges

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sulfonamide derivative as well as preparation method and application thereof
  • Sulfonamide derivative as well as preparation method and application thereof
  • Sulfonamide derivative as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Preparation of N-[(diethoxyphosphono)-benzyl]-benzenesulfonamide (IIa):

[0026] Weigh 1.0mmol of intermediate 1 (diethyl α-aminobenzylphosphonate) and 1.0mmol of benzenesulfonyl chloride in a 50mL reaction flask, then add 10mL of dichloromethane and 0.5mmol of basic ionic liquid [Bmim]OH, Heated to reflux, TLC monitored the reaction, after 3 hours of reaction, the solvent was concentrated by a rotary evaporator, separated and purified by column chromatography (eluent: ethyl acetate:petroleum ether=1:2), and a white solid was obtained, which was the target compound (Ⅱa). Yield 80.6%. compound 1 H NMR, 13 C NMR and MS: 1 H-NMR (400MHz, CDCl 3 )δ:6.98-7.72(m,11H,ArH+NH),4.78-4.87(q,1H,J=36.0Hz,PCH),4.25-4.28(m,2H,OCH 2 ),3.78-3.84(m,1H,OCH 2 ),3.49-3.57(m,1H,OCH 2 ),1.34(t,3H,J=16.0Hz,CH 3 ),0.98(t,3H,J=12.0Hz,CH 3 ). 13 C-NMR (100MHz, CDCl 3 )δ: 16.0, 16.4, 55.0, 63.6, 64.1, 126.4, 127.1, 127.2, 127.4, 127.5, 128.3, 128.6, 129.0, 129.1, 132.3, 135.6, 138.1. ES...

example 1

[0027] The above example 1, if according to the following method:

[0028] Weigh 1.0mmol of intermediate 1 (diethyl α-aminobenzylphosphonate) and 1.0mmol of benzenesulfonyl chloride in a 50mL reaction flask, then add 10mL of dichloromethane and 1.0mmol of triethylamine, heat to reflux, and monitor by TLC After 13 hours of reaction, the solvent was concentrated by a rotary evaporator, separated and purified by column chromatography (eluent: ethyl acetate:petroleum ether=1:2), and a white solid was obtained, which was the target compound (IIa), with a yield of 39.5%.

Embodiment 2

[0030] Preparation of N-[(diethoxyphosphono)-benzyl]-2-thiophenesulfonamide (Ⅱb)

[0031] Weigh 1.0mmol intermediate 1 (diethyl α-aminobenzylphosphonate) and 1.0mmol thiophene-2-sulfonyl chloride in a 50mL reaction flask, then add 10mL dichloromethane and 0.5mmol basic ionic liquid [Bmim ]OH, heated to reflux, and TLC monitored the reaction. After completion, the solvent was concentrated by a rotary evaporator, separated and purified by column chromatography (eluent was ethyl acetate:petroleum ether=1:2), and a white solid was obtained, which was the target compound (Ⅱb). , yield 84.3%. compound 1 H NMR, 13 C NMR and MS: 1 H-NMR (400MHz, CDCl 3 )δ: 7.46-7.53 (m, 1H, NH), 6.67-7.28 (m, 8H, ArH), 4.72-4.80 (q, 1H, J = 32.0Hz, PCH), 4.22-4.29 (m, 2H, OCH 2 ),3.81-3.87(m,1H,OCH 2 ),3.52-3.62(m,1H,OCH 2 ),1.33(t,3H,J=16.0Hz,CH 3 ),0.99(t,3H,J=16.0Hz,CH 3 ). 13 C-NMR (100MHz, CDCl 3 )δ: 16.0, 16.4, 54.7, 63.7, 64.0, 126.7, 127.9, 128.0, 128.1, 128.2, 131.3, 132.0, 133.3, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a sulfonamide derivative in the field of antibacterial compounds. The sulfonamide derivative has a structural formula as shown in formula II: (as shown in the specification); and the preparation method comprises the following steps: feeding and mixing sulfonyl chloride, an intermediate I and [Bmim]OH ionic liquid at a molar ratio of 1 to 1 to 0.5; then, adding anhydrous dichloromethane to obtain a mixture, wherein the dosage of anhydrous dichloromethane is that 10-15 mL of anhydrous dichloromethane is added into per 1 mmol of sulfonyl chloride; heating and refluxing for3-4 h after stirring the mixture uniformly; concentrating under reduced pressure to obtain a coarse product after refluxing; separating and purifying the coarse product with column chromatography toobtain a target product sulfonamide derivative II. The sulfonamide derivative II designed and synthesized in the invention has an excellent antibacterial effect against Gram-negative bacteria and Gram-positive bacteria, and particularly has significant antibacterial activity against S. aureus, E. coli, MRSA and MREC.

Description

technical field [0001] The invention belongs to the field of antibacterial compounds, and in particular relates to a sulfonamide derivative and its preparation method and application. Background technique [0002] In recent years, with the widespread use and abuse of antibacterial drugs in clinical practice, drug resistance has become a difficult global problem. Many patients with bacterial infections are facing a situation where there is no cure. bring unprecedented challenges. Therefore, it is imminent to develop novel antibacterial drugs. [0003] Since the German scientist Domagk discovered in 1932 that the sulfonamide dye Baituozi has a therapeutic effect on bacterial infections in experimental animals, the research on this type of drug has developed rapidly, and then a variety of sulfonamide antibacterial drugs have been used in clinical practice. As the earliest synthetic antibacterial drug, the discovery, application, and clarification of the mechanism of sulfonami...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07F9/40A61K31/662A61P31/02A61P31/04
CPCA61P31/02A61P31/04C07F9/4043Y02A50/30
Inventor 杨家强邓玲雷延燕安家丽
Owner ZUNYI MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products